another company we're looking at is clovi as. with an approved drug, ariad, who had a new drug on the market. we'll see which patients it might be used best in and there was a big mover in. pharmas. brist bristol-myers. they'll have a lot more data at the meeting they'll be looking for. whether they turn that decline down after they got that down-grade, melissa. >> meg, thanks for that. >> one of the things you see, most of those names peaked in march. >> the big space bio tech is interested in is oncology drugs. the cancer drugs. the real growth opportunities. the thing about playing any one of these, they play at astonishing modules. there are actually a lot of companies not trading in obscene multiples, one name that comes to mind is cell jean. the way to capture those plays without taking the risk. would be on the names of incyte and clovis. one way is to play ibb. take advantage of the fact that options prices are up. jefferys is holding one. i would simply sell a put spread on ibb. the one that i'm looking at specifically i

another is clovis.p a couple of weeks ago and expecting more at the meeting which could be good. and an approved drug, pulled last year due to safety concerns, back on the market. we're looking at more data on that, looking to see doses and the patients. and the big mover, that was bristol meyers got downgraded after the data, with the immuno therapy. see this if they do that after the downgrade. >> thanks for that. one thing you notice about the charts, most of the names peaked beginning of march. so will this help? >> yeah, the big space in biotech was specifically the oncology drugs. the cancer drugs in particular. that was the growth opportunities. they trade at astonishing multiples because their speculative. based on the forecast that these things are going to come up. a lot of companies in the same space, one is cell gene. and the way to capture the plays without the risk on the high volatility with insight or clovis, both are expected to move 16 to 20% in the options market, just play ibb. take

clovis officer joel acosta, now retired, sees an opportunity to perform a pitt maneuver. >> it involvest with the suspect vehicle in one of the recorder panels, and what it does essentially is causes them to spin out of control. as i move in a position to do that, he repositioned his vehicle. we were going to basically hit head on. my concern is if i collide head on, what's going to happen to her? >> he opts to brake at the last second, but not before locking eyes with the suspect. >> i see this person who is just laughing. his eyes are open. he's enjoying himself. it's obvious to me, anyway, that his intent is to get away or die trying. >> moments later sahara's car is rammed by another police vehicle. the suspect keeps driving, mounting a median and steering the battered honda to a gas station across the street. there he's hit again but sahareth keeps moving. this time police use their guns to stop him, opening fire with a barrage of bullets. >> i could hear bullets impacting the walls around me. i was extremely concerned because i knew there's a passenger in this car. in my mind i'm

oncology, and we saw some data from azn a few weeks ago but clovis looked better based on data.search saturday at asco which could drive clovis up further. >> gilead, it was a ridiculous strong quarter. but they got caught up with the rest of the biotechs, all got sold off. the stock went from 84 in february down to 64. and it's finally getting the footing back as the rest of the space recovers. i think right now in the biotech space, gilead as interesting stock out there. >> cldx, the stock is down 40% year-to-date. and it's down, it's lost half of the value basically since it topped 30 back in february. so 14 -- i'm watching this one. they are a big cancer player. we'll see obviously the street has not been better with them. but that's one of the reasons to watch this one closely. >> switching gears a little bit, they had problems in the past with data being leaked prior to that conference. will that happen again? they try to be tight with it. that's something you have to watch. and if you see a stock starting to move you have to start to wonder. we did see a couple of stocks

another is clovis. expecting more at the meeting which could be good.d last year due to safety concerns, back on the market. looking to see doses and the patients. and the big mover, that was bristol meyers got downgraded after the data, with the immeow know thera -- immuno therapy. see this if they do that after the downgrade. >> thanks for that. one thing you notice about the charts, most of the names peaked beginning of march. so will this help? >> yeah, the big space in bicycle tech was specifically the oncology drugs. t the cancer drugs in particular. that was the growth opportunities. they trade at astonishing multiples because their speculati speculative. a lot of companies in the same space, one is cell gene. and the way to capture the plays without the risk on the high volatility with insight or clovis, both are expected to move 16 to 20% in the options market, just play ibb. take advantage of the fact that options prices are up. not only because of this, but there are health care conferences. goldman sachs is having one. sell a put spread on i

in an interesting twist we saw the rise of a small company called clovis, which has a similar drug. so that stuck went way up. >> all right, thank you very much. to read more about the companies working on cancer treatments head to our website at nbr.com. >>> and coming up. the fight for your car's dashboard and why apple wants it to look like an iphone. >>> general motors has already recalled 8 million cars this year alone and just today, five more recalls were announced. adding another 2.7 million vehicles to the list. today's new recalls involve cadillacs, corvettes, chevy suvs and new chevy malibus, that range from tail lights to power brake software problems, gm says these problems will cost the company $200 million in charges this summer. go to nbr.com for more information. >>> and apple and pioneer are teaming up to make any vehicle a smarter one. they have created car play, an in-dash multi-media system that brings the internet right to the driver's seat. josh lipton has more. >> reporter: and certain functi functions. for the tech titans, the next big battle is not for your

we had an he can clovis look at that last week.responded to 170 water rescues and that is compared to only 2 in 200,000. 200,000. >> now the most common rescue call is a swimmer in distress and they know how to get to those victims and get the grimes to save -- get the victims to safety in all kind of situations. >>> we will have more on the impact it's having on traffic in san francisco's busiest street. >>> and a shocking attack involves a four-year-old girl and a crowbar. stay right here with us. dog: get four years get four years interest-free financing on the entire tempur-pedic cloud collection, even a queen size sealy gel memory foam mattress for just $497. the memorial day sale is ending soon.

skipping bail in a narcotics case. 15 minutes earlier the 26-year-old had taken off when cops in nearby clovisry to bring him in. in the car with him, his on again/off again girlfriend, and the mother of his two sons who shared her story with local television. >> i was just scared, and i'm still shook up. i begged him to stop. to just let me out. just stop. >> by chance tony kirkpatrick, a fresno camera operator is in the vicinity and captures this dramatic video. >> i just started rolling. i just kept rolling. as you could tell, the camera was like crooked because i was so nervous. >> police fear he could be high on drugs and heavily armed. as the suspect approaches a busy intersection. the officer now retired sees an opportunity to perform a pit maneuver. >> it involves making contact with the suspect vehicle in one of the recorder panels, and what it does essentially is kauss them to spin out of control. as i move in a position to do that, he repositioned his vehicle. we were going to basically hit head on. my concern is if i collide head on, what's going to happen to her? >> he opts to bra

seeing good news in clovis.presenting data on a similar drug people to be happy with. bristle merck. back to you, guys. >> that's one we mentioned when we discussed it with the city's analyst. >> we saw the stock within a few days. now it's back down to, guess, what, a 50 handle. they just recorded a couple weeks ago it wasn't great. it's about the cash burn and can they get things out in time. it looks like the answer might be yes. with the 12% shortage where it currently is, i think it's probably some more on the upside. >> medical marijuana is turning over a new leaf. kicking off the stigma of getting high on another ingredient. the first drug will be able to treat cannabis. it's a cannabinoid platform you're using. can you explain? >> other than thc which do not make you high and have medicinal properties. so we have been interested into a cannabinoid which appears to have effects in treating seizures in children with epilepsy. >> how big of a market could that be for you? >> i think we're particularly inter

clovis, actually that data. some analysts saying that's a similar drug to clovis's drug.might be more potent and might have fewer effects. finally, we will talk about insight. that company has an approved drug. it is expanding into pancreatic cancer. they are looking to see what patients will work best on isn't as strong as they thought it would be. and an experimental drug focusing on another oncology drug. maybe not as strong as people were looking for. >> asco. >> may 30th to june 3, chicago. >> are you going? >> i am. we're hoping to do a few interviews with you. >> she went to wellsly. >> that is why. >> really? i have to rethink my whole southern sisters. >> the english major i had there was very helpful. >> excellent. thank you. coming up, senator bob corker. cory booker. on the -- here i thought we had core where booker. it's bob corker. >> it is like when i said twitter was going to open flat. it is exactly like that. i can see the confusion. on the need for mortgage insurance reform, sanctions against russia. and volkswagen in chattanooga. check out the futures